Get started

Hospitalstock

Dr Reddy is Ready to fly in blue sky, Short term Trading Idea .I hope you all will be doing good in your life and your trading as well. I have brought a stock which has formed a pull back pattern and taken support at previous breakout zone. Stock name is Dr. Reddy's Laboratories Ltd and it is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Stock is good for short term trading idea as it has taken support in the previous breakout zone. Stock is good for long term investing as well. This can be best SIP stock to invest and get handsome returns in future. Market Cap ₹ 1,09,439 Cr. Current Price ₹ 1,312 High / Low ₹ 1,421 / 1,041 Stock P/E 19.7 Book Value ₹ 339 Dividend Yield 0.61 % ROCE 26.5 % ROE 21.4 % Face Value ₹ 1.00 Industry PE 34.5 Debt ₹ 2,002 Cr. EPS ₹ 66.7 Promoter holding 26.6 % Intrinsic Value ₹ 1,033 Pledged percentage 0.00 % EVEBITDA 12.3 Change in Prom Hold -0.01 % Profit Var 5Yrs 24.4 % Sales growth 5Years 12.6 % Return over 5years 18.9 % Debt to equity 0.07 Net profit ₹ 5,565 Cr. ROE 5Yr 16.7 % Profit growth 17.8 % Earnings yield 6.77 % PEG Ratio 0.81 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:DRREDDYLong
by TraderRahulPal
7
Short Term Trading idea in Dr. Lal Pathlabs, 17% upside possibleHello everyone, i hope you all will be doing good in your life and your trading as well. Today i have just brought a short term idea in Lab stocks. Stock name is Dr. Lal Pathlabs Ltd. and it is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. Stock has given near term consolidation breakout on daily and weekly time frame. Stock can travel towards all time high levels from here, I have already mention all the levels like stop loss and Targets. Stock is really good for long term investing as well. But for now i have just added kind of short term Idea. Please follow the levels. Market Cap ₹ 29,198 Cr. Current Price ₹ 3,494 High / Low ₹ 3,525 / 1,943 Stock P/E 76.5 Book Value ₹ 222 Dividend Yield 0.69 % ROCE 25.2 % ROE 20.4 % Face Value ₹ 10.0 Industry PE 53.6 Debt ₹ 247 Cr. EPS ₹ 45.7 Promoter holding 54.6 % Intrinsic Value ₹ 743 Pledged percentage 0.00 % EVEBITDA 40.4 Change in Prom Hold 0.00 % Profit Var 5Yrs 12.4 % Sales growth 5Years 13.1 % Return over 5years 20.9 % Debt to equity 0.13 Net profit ₹ 386 Cr. ROE 5Yr 21.3 % Profit growth 44.6 % Earnings yield 1.97 % PEG Ratio 6.15 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:LALPATHLABLong
by TraderRahulPal
1
India's 4th largest pharma company has given breakout..Hello Guy's i hope you all will be doing good in your life and your trading as well. I have brought another stock which has given breakout of small rectangle pattern on daily timeframe. Company has good management with proven profits making record, it is 4th Consumer Healthcare brands Market ranked #1 in their categories. Mankind is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. If i talk about technicals, stock has given small Rectangle pattern breakout and stock has came down to retest the levels. Indicators like MACD and RSI start giving bullish crossover, Price is above 200-DEMA. All is indicating bullish reversal in stock. There is higher chances we can see good bullish momentum in near term. Stock is good for investment like short term to medium term. And one more thing, if anybody wants to consider this stock as long term, then it is absolutely good for that, even i will suggest to do SIP in this. Market Cap ₹ 92,165 Cr. Current Price ₹ 2,301 High / Low ₹ 2,375 / 1,241 Stock P/E 55.8 Book Value ₹ 216 Dividend Yield 0.00 % ROCE 20.7 % ROE 17.0 % Face Value ₹ 1.00 Industry PE 32.8 Debt ₹ 9.74 Cr. EPS ₹ 41.2 Promoter holding 76.5 % Intrinsic Value ₹ 851 Pledged percentage 0.00 % EVEBITDA 38.6 Change in Prom Hold 0.00 % Profit Var 5Yrs 11.9 % Sales growth 5Years 15.7 % Return over 5years % Debt to equity 0.00 Net profit ₹ 1,650 Cr. ROE 5Yr 21.6 % Profit growth 39.3 % Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:MANKINDLong
by TraderRahulPal
2
this Breakout given stock can give you 17% return in short termHello Guy's i have brought another stock which can give you 17% return in short term. Well this is good proven stock in past, this has really given handsome returns to their investors, but now we are taking as trading bet for short term. But still if anybody is thinking for long term can definitely go as this is just a small cap company right now, it has potential to become large cap in coming few years. Let's focus on company background:- About Company:- Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services. KEY POINTS:- Services Provided: The company runs a 227 bed multi-specialty hospital at Trichy, Tamil Nadu. It offers services in neurology, nephrology, obstetrics, gynecology, pediatrics, neonatology, cardiology, ENT, dental, orthopedics, joint replacement, liver transplant surgery, neurosurgery, plastic surgery, etc. Specialty Clinics: The company also has dedicated centers to provide holistic care for women and children in the fields of Pediatrics, Neonatology, Obstetrics Care, Gynaec Services and Family Planning Services. Apart from this, KMC has also launched advanced Liver Care Clinic and Advanced Diabetes Management Program Key Statistics: The company is present in 5 locations with 7 hospitals and 1,175 beds in total. As of now, the company gives treatment to ~5 lacs patients annually. The company has done >60'000 kidney dialysis and >10'000 heart surgeries until now and >2'000 Gastro, Neuro and Cancer procedures each along with Joint Replacements. International Patient Services: The company also provides medical services especially for the international patients. These specific services include: Second Medical Opinion Diet Management Accommodation Airport Pickup & Drop Travel Desk. Market Cap ₹ 1,574 Cr. Current Price ₹ 96.5 High / Low ₹ 102 / 52.0 Stock P/E 57.5 Book Value ₹ 7.80 Dividend Yield 0.00 % ROCE 26.7 % ROE 26.7 % Face Value ₹ 1.00 Industry PE 48.6 Debt ₹ 62.2 Cr. EPS ₹ 1.68 Promoter holding 75.0 % Intrinsic Value ₹ 34.2 Pledged percentage 0.00 % EVEBITDA 34.4 Change in Prom Hold 0.00 % Profit Var 5Yrs 31.9 % Sales growth 5Years 17.1 % Return over 5years 51.5 % Debt to equity 0.49 Net profit ₹ 27.4 Cr. ROE 5Yr 26.8 % Profit growth 7.50 % PROS:- Company has delivered good profit growth of 31.9% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 27.2% Company's median sales growth is 16.4% of last 10 years CONS: [- Stock is trading at 12.4 times its book value Though the company is reporting repeated profits, it is not paying out dividend Company might be capitalizing the interest cost Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
BSE:KMCSHILLong
by TraderRahulPal